Matches in Wikidata for { <http://www.wikidata.org/entity/Q90799624> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q90799624 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q90799624 description "scientific article published on 19 March 2020" @default.
- Q90799624 description "wetenschappelijk artikel" @default.
- Q90799624 description "наукова стаття, опублікована 19 березня 2020" @default.
- Q90799624 description "գիտական հոդված հրատարակված 2020 թվականի մարտի 19-ին" @default.
- Q90799624 name "Evolocumab Use in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-blind BEIJERINCK Study" @default.
- Q90799624 name "Evolocumab Use in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-blind BEIJERINCK Study" @default.
- Q90799624 type Item @default.
- Q90799624 label "Evolocumab Use in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-blind BEIJERINCK Study" @default.
- Q90799624 label "Evolocumab Use in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-blind BEIJERINCK Study" @default.
- Q90799624 prefLabel "Evolocumab Use in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-blind BEIJERINCK Study" @default.
- Q90799624 prefLabel "Evolocumab Use in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-blind BEIJERINCK Study" @default.
- Q90799624 P1433 Q90799624-82105921-23AB-40B3-9E40-B1E75B690EA1 @default.
- Q90799624 P1476 Q90799624-44C0CF37-C343-41C6-87B9-40212892AA67 @default.
- Q90799624 P2093 Q90799624-1CF876D4-924E-466C-A362-10BBC2C70BF2 @default.
- Q90799624 P2093 Q90799624-3DD2EDC1-EEA2-4695-861C-43DCCB68B9BB @default.
- Q90799624 P2093 Q90799624-3F19ABF1-6101-4595-97F6-9F1C90D18A02 @default.
- Q90799624 P2093 Q90799624-575783DB-C9C6-4DBB-93CE-1D0113654B0E @default.
- Q90799624 P2093 Q90799624-9E9CD592-C538-4827-B4C8-BF440A0DF763 @default.
- Q90799624 P2093 Q90799624-BD1D2E67-53AC-4DAD-B41F-3E5E05FC88EA @default.
- Q90799624 P2093 Q90799624-DB7B85EF-5FC5-4A56-87CD-873156479249 @default.
- Q90799624 P2093 Q90799624-E2EFDE10-3D78-4EA5-AF28-87287A291B08 @default.
- Q90799624 P31 Q90799624-6B4110B2-0548-48AE-8542-141514804BF9 @default.
- Q90799624 P356 Q90799624-37C42D40-2816-4D52-A978-19D305FEF3D7 @default.
- Q90799624 P577 Q90799624-506B04C9-BFE6-466B-BD0E-EC4B1EA458A1 @default.
- Q90799624 P698 Q90799624-2F64E21B-943D-41A4-83FB-98A2CAE46716 @default.
- Q90799624 P921 Q90799624-B97871F3-00DA-49C8-890B-FCCC9251C8F5 @default.
- Q90799624 P356 J.JACC.2020.03.025 @default.
- Q90799624 P698 32234462 @default.
- Q90799624 P1433 Q2984355 @default.
- Q90799624 P1476 "Evolocumab Use in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-blind BEIJERINCK Study" @default.
- Q90799624 P2093 "Alexandra Calmy" @default.
- Q90799624 P2093 "Bruno Caramelli" @default.
- Q90799624 P2093 "Franck Boccara" @default.
- Q90799624 P2093 "J Antonio G López" @default.
- Q90799624 P2093 "Marcoli Cyrille" @default.
- Q90799624 P2093 "Princy N Kumar" @default.
- Q90799624 P2093 "Robert S Rosenson" @default.
- Q90799624 P2093 "Sarah Bray" @default.
- Q90799624 P31 Q13442814 @default.
- Q90799624 P356 "10.1016/J.JACC.2020.03.025" @default.
- Q90799624 P577 "2020-03-19T00:00:00Z" @default.
- Q90799624 P698 "32234462" @default.
- Q90799624 P921 Q66291209 @default.